Hofmann, C A <br/><br/>
Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.  [electronic resource] 

 -  Endocrinology  Feb 1992 
 - 735-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0013-7227 
<br/><br/><label>Standard No.: </label>10.1210/endo.130.2.1733721  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Crosses, Genetic<br/>Diabetes Mellitus--genetics<br/>Diabetes Mellitus, Experimental--genetics<br/>Female<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--blood<br/>Insulin Resistance<br/>Kinetics<br/>Liver--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Obese<br/>Monosaccharide Transport Proteins--genetics<br/>Obesity<br/>Phosphoenolpyruvate Carboxykinase (GTP)--genetics<br/>Pioglitazone<br/>RNA, Messenger--genetics<br/>Thiazoles--pharmacology<br/>Thiazolidinediones